Companies Choose ALPHADAS®, Logos Technologies Early Phase EDC System

October 18, 2010
Company News Release

Richmond Pharmacology, Community Research, and Fundación de Investigación de Diego, Puerto Rico has selected the ALPHADAS' early phase, e-source data capture system and site automation software suite which gives clinical research sites tools to accelerate and streamline their clinical trial operations and service. ALPHADAS is to be implemented initially in Richmond Pharmacology's MHRA Phase I Accredited facility, located in MayDay Hospital, London, UK as well as in Community Research's research facility, located in Cincinnati, Ohio, USA. ALPHADAS will be used in Fundación's new, purpose built 20,000 sq ft, research facility, located in San Juan, Puerto Rico. Fundacion de Investigacion new facility includes a 30 bed phase 1 unit, expanded ambulatory clinical trials space, and a bio-analytical laboratory.

ALPHADAS, is an e-Source, pro-active EDC system designed specifically for early phase clinical trials. Logos Technologies continues to invest in ALPHADAS, increasing its performance and functionality.